Dehydroandrographolide targets CD300f and negatively regulated MRGPRX2‐induced pseudo‐allergic reaction
Sign Up to like & getrecommendations! Published in 2022 at "Phytotherapy Research"
DOI: 10.1002/ptr.7445
Abstract: Mas‐related G protein‐coupled receptor X2 (MRGPRX2) mediates mast cells (MCs) activation, which is a key target for the treatment of allergic diseases. However, there are few drugs targeting MRGPRX2. Leukocyte mono‐immunoglobulin‐like receptor 3 (CD300f) is… read more here.
Keywords: negatively regulated; pseudo allergic; regulated mrgprx2; mrgprx2 ... See more keywords